Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Distinction between breast cancer cell subtypes using third harmonic generation microscopy.

Gavgiotaki E, Filippidis G, Markomanolaki H, Kenanakis G, Agelaki S, Georgoulias V, Athanassakis I.

J Biophotonics. 2017 Sep;10(9):1152-1162. doi: 10.1002/jbio.201600173. Epub 2016 Oct 18.

PMID:
27753229
2.

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer.

Agelaki S, Kalykaki A, Markomanolaki H, Papadaki MA, Kallergi G, Hatzidaki D, Kalbakis K, Mavroudis D, Georgoulias V.

PLoS One. 2015 Jun 17;10(6):e0123683. doi: 10.1371/journal.pone.0123683. eCollection 2015.

3.

Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.

Spiliotaki M, Mavroudis D, Kapranou K, Markomanolaki H, Kallergi G, Koinis F, Kalbakis K, Georgoulias V, Agelaki S.

Breast Cancer Res. 2014 Nov 29;16(6):485. doi: 10.1186/s13058-014-0485-8.

4.

Apoptotic circulating tumor cells in early and metastatic breast cancer patients.

Kallergi G, Konstantinidis G, Markomanolaki H, Papadaki MA, Mavroudis D, Stournaras C, Georgoulias V, Agelaki S.

Mol Cancer Ther. 2013 Sep;12(9):1886-95. doi: 10.1158/1535-7163.MCT-12-1167. Epub 2013 Jun 18.

5.

Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect.

Spiliotaki M, Markomanolaki H, Mela M, Mavroudis D, Georgoulias V, Agelaki S.

Lung Cancer. 2011 Aug;73(2):158-65. doi: 10.1016/j.lungcan.2010.11.010. Epub 2010 Dec 28.

PMID:
21190751
6.

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

Kallergi G, Markomanolaki H, Giannoukaraki V, Papadaki MA, Strati A, Lianidou ES, Georgoulias V, Mavroudis D, Agelaki S.

Breast Cancer Res. 2009;11(6):R84. doi: 10.1186/bcr2452. Epub 2009 Nov 17.

7.

Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.

Agelaki S, Spiliotaki M, Markomanolaki H, Kallergi G, Mavroudis D, Georgoulias V, Stournaras C.

Cancer Biol Ther. 2009 Aug;8(15):1470-7. Epub 2009 Aug 8.

PMID:
19483462
8.

Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells.

Kallergi G, Agelaki S, Markomanolaki H, Georgoulias V, Stournaras C.

Cell Physiol Biochem. 2007;20(6):977-86.

Supplemental Content

Loading ...
Support Center